Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
Cancers - Switzerland
doi 10.3390/cancers12030719
Full Text
Open PDFAbstract
Available in full text
Date
March 19, 2020
Authors
Publisher
MDPI AG